Human Mesenchymal Stem Cells – Endometrium

Human Mesenchymal Stem Cells, Endometrium (eMSCs), are a distinct subset of MSCs derived from the regenerative endometrial tissue of the uterus. The endometrium’s natural cycle of growth, differentiation, and shedding underscores the regenerative capabilities of these cells, making eMSCs particularly valuable for research in tissue repair, regenerative medicine, and gynecological studies. Their unique origin also contributes to their potential in studying immune-related disorders and inflammatory conditions, given their notable immunomodulatory properties.

These eMSCs retain the hallmark multipotency of MSCs, with proven capabilities to differentiate into adipocytes, osteoblasts, and chondrocytes under controlled in vitro conditions using specific differentiation media. This differentiation capacity, coupled with their origin, makes eMSCs especially relevant in studies involving tissue engineering and regenerative therapies. Our eMSCs are cryopreserved at an early passage to ensure maximum viability and functionality upon thawing, with each cryovial containing 1 x 106 cells at a viability rate of 92% to 95%, confirmed by the Trypan Blue dye exclusion test. The cells are ethically sourced from healthy donors with informed consent, and each batch undergoes comprehensive quality control to verify cell identification, purity, potency, viability, and appropriateness for in vitro research applications, ensuring the highest quality for scientific investigations.